BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3900582)

  • 1. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection.
    Miura K; Takahashi Y; Shirasawa H
    Lab Invest; 1985 Oct; 53(4):453-63. PubMed ID: 3900582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental amyloidosis. Role of the hepatocytes and Kupffer cells in amyloid formation.
    Uchino F; Takahashi M; Yokota T; Ishihara T
    Appl Pathol; 1985; 3(1-2):78-87. PubMed ID: 3915947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic demonstration of cytoplasmic ASSAM-related antigenic substance (CASSAM) by an immunoperoxidase technique.
    Takeshita S; Higuchi K; Hosokawa M; Matsumura A; Higuchi K; Kohno A; Matsushita M; Yonezu T; Takeda T
    Am J Pathol; 1985 Dec; 121(3):455-65. PubMed ID: 3907365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein.
    Benson MD; Kleiner E
    J Immunol; 1980 Feb; 124(2):495-9. PubMed ID: 6985931
    [No Abstract]   [Full Text] [Related]  

  • 5. NTP technical report on the toxicity studies of Cupric Sulfate (CAS No. 7758-99-8) Administered in Drinking Water and Feed to F344/N Rats and B6C3F1 Mice.
    Hebert C
    Toxic Rep Ser; 1993 Jul; 29():1-D3. PubMed ID: 12209195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid.
    Kluve-Beckerman B; Manaloor JJ; Liepnieks JJ
    Arthritis Rheum; 2002 Jul; 46(7):1905-13. PubMed ID: 12124875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation from SAA2-fibrils to AA-fibrils in amyloid fibrillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies.
    Arai K; Miura K; Baba S; Shirasawa H
    J Pathol; 1994 Jun; 173(2):127-34. PubMed ID: 8089807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid P-component in mice injected with casein: identification in amyloid deposits and in the cytoplasm of hepatocytes.
    Baltz ML; Dyck RF; Pepys MB
    Immunology; 1980 Sep; 41(1):59-66. PubMed ID: 7000694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural evidence for the synthesis of serum amyloid A protein by murine hepatocytes.
    Takahashi M; Yokota T; Yamashita Y; Ishihara T; Uchino F
    Lab Invest; 1985 Feb; 52(2):220-3. PubMed ID: 3881624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.
    Kawahara E; Shiroo M; Nakanishi I; Migita S
    Am J Pathol; 1989 Jun; 134(6):1305-14. PubMed ID: 2757120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy.
    Kisilevsky R; Boudreau L; Foster D
    Lab Invest; 1983 Jan; 48(1):60-7. PubMed ID: 6823092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis.
    Doepel FM; Glorioso JC; Newcomer CE; Skinner M; Abrams GD
    Lab Invest; 1981 Jul; 45(1):7-13. PubMed ID: 7253566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation.
    Shirahama T; Miura K; Ju ST; Kisilevsky R; Gruys E; Cohen AS
    Lab Invest; 1990 Jan; 62(1):61-8. PubMed ID: 2296158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury.
    Cho K; Pham TN; Crivello SD; Jeong J; Green TL; Greenhalgh DG
    Shock; 2004 Feb; 21(2):144-50. PubMed ID: 14752288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous participation of the hepatocyte population in amyloid protein AA synthesis.
    Shirahama T; Skinner M; Cohen AS
    Cell Biol Int Rep; 1984 Oct; 8(10):849-56. PubMed ID: 6509560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of high-density lipoproteins (HDL) in the clearance of intravenously administered bacterial lipopolysaccharides (LPS) in mice.
    König V; Hopf U; Möller B; Lobeck H; Assmann G; Freudenberg M; Galanos C
    Hepatogastroenterology; 1988 Jun; 35(3):111-5. PubMed ID: 3042575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-enhancing factor mediates amyloid formation on fibroblasts via a nidus/template mechanism.
    Magy N; Liepnieks JJ; Benson MD; Kluve-Beckerman B
    Arthritis Rheum; 2003 May; 48(5):1430-7. PubMed ID: 12746917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the combined lipase deficiency mutation (cld/cld) on ultrastructure of tissues in mice. Diaphragm, heart, brown adipose tissue, lung, and liver.
    Blanchette-Mackie EJ; Wetzel MG; Chernick SS; Paterniti JR; Brown WV; Scow RO
    Lab Invest; 1986 Sep; 55(3):347-62. PubMed ID: 3747449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition.
    Kisilevsky R; Benson MD; Axelrad MA; Boudreau L
    Lab Invest; 1979 Sep; 41(3):206-10. PubMed ID: 470340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.